August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Jordi Remon: Adagrasib and pembrolizumab show impressive mPFS in KRAS G12C mutant NSCLC
Mar 28, 2025, 14:31

Jordi Remon: Adagrasib and pembrolizumab show impressive mPFS in KRAS G12C mutant NSCLC

Jordi Remon, Thoracic Oncologist at CIOCC Barcelona, shared a post on X:

“Adagrasib 400 mg and Pembrolizumab impressive mPFS in KRAS G12C mutant NSCLC and PDL1 >50% and good safety.

Better than IO or CT and IO alone. Good chem-free strategy for patients.

Await the ph3 trial.”

Jordi Remon: Adagrasib and pembrolizumab show impressive mPFS in KRAS G12C mutant NSCLC

More posts featuring Jordi Remon.